Study of Brentuximab Vedotin as Therapy After Autologous Stem Cell Transplant in Cluster of Differentiation Antigen 30 (CD30) Positive Peripheral TCell Lymphomas
Clinical trial NCT04334174 · WITHDRAWN
Trial details
- NCT number
- NCT04334174
- Sponsor
- University of Kansas Medical Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-29
- Primary completion
- 2022-12-14
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.